{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:04:02Z","timestamp":1789535042811,"version":"build-2803163510"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:p>Continuous glucose monitoring (CGM) has transformed diabetes management by providing real-time glucose measurements and supporting improved glycemic control. Consequently, the methodological quality of CGM accuracy studies has become increasingly important for clinicians, regulatory agencies, and healthcare decision-makers. The recent real-world evaluation of the Sinocare iCan i3 CGM system provides valuable evidence regarding device performance under routine clinical conditions. However, several methodological aspects warrant further consideration before the reported findings can be generalized to clinical practice. This perspective critically examines key aspects of CGM validation, including study design, selection of the reference glucose measurement, statistical methodology, temporal pairing strategies, sensor survival analysis, potential sponsorship-related bias, and interpretation of clinical accuracy metrics. We also discuss additional methodological considerations that were not fully addressed in the original publication, including uncertainty estimation, subgroup analyses, longitudinal sensor performance, missing-data mechanisms, and reproducibility assessment. Finally, we propose recommendations aimed at improving the methodological rigor of future real-world CGM validation studies and facilitating meaningful comparisons across CGM technologies.<\/jats:p>","DOI":"10.3389\/fcdhc.2026.1941126","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:29:00Z","timestamp":1789532940000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Toward standardized continuous glucose monitoring validation: lessons from the Sinocare iCan i3 accuracy study"],"prefix":"10.3389","volume":"7","author":[{"given":"Auda","family":"Ameur","sequence":"first","affiliation":[{"name":"Department of Pediatrics B \u2018Amilcar Cabral, University Hospital of Oran","place":["Oran, Algeria"]},{"name":"Faculty of Medicine, University of Oran 1","place":["Oran, Algeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2534","article-title":"Diabetes technology\u2014continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: An Endocrine Society clinical practice guideline","volume":"101","author":"Peters","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241296097","article-title":"The need for standardization of continuous glucose monitoring performance evaluation","volume":"20","author":"Pleus","year":"2026","journal-title":"J Diabetes Sci Technol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S007","article-title":"Diabetes technology: Standards of care in diabetes\u20142026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.04.008","article-title":"American Association of Clinical Endocrinology clinical practice guideline: The use of advanced technology in the management of persons with diabetes mellitus","volume":"27","author":"Grunberger","year":"2021","journal-title":"Endocr Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-025-01773-0","article-title":"Accuracy and reliability of the Sinocare continuous glucose monitoring system","volume":"16","author":"Bhargava","year":"2025","journal-title":"Diabetes Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-026-01840-0","article-title":"Letter to the editor regarding \u201cAccuracy and reliability of the Sinocare continuous glucose monitoring system","volume":"17","author":"G\u00fcrb\u00fcz","year":"2026","journal-title":"Diabetes Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14981","article-title":"Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis","volume":"25","author":"Di Molfetta","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818812062","article-title":"Measures of accuracy for continuous glucose monitoring and blood glucose monitoring devices","volume":"13","author":"Freckmann","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231159657","article-title":"Performance of three continuous glucose monitoring systems in adults with type 1 diabetes","volume":"18","author":"K\u00f6lle","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2025.0139","article-title":"Accuracy of the 15.5-day G7 iCGM in adults with diabetes","volume":"27","author":"Garg","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0011","article-title":"Accuracy and safety of Dexcom G7 continuous glucose monitoring in adults with diabetes","volume":"24","author":"Garg","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820958754","article-title":"Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes","volume":"16","author":"Alva","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0087","article-title":"Accuracy of a fourth-generation subcutaneous continuous glucose sensor","volume":"19","author":"Christiansen","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221085273","article-title":"A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings","volume":"17","author":"Klonoff","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70288","article-title":"Continuous glucose monitoring and microvascular complications in diabetes","volume":"28","author":"Anagnostopoulou","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2019.0121","article-title":"Continuous glucose monitoring sensors for diabetes management: A review of technologies and applications","volume":"43","author":"Cappon","year":"2019","journal-title":"Diabetes Metab J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1089\/dia.2021.0115","article-title":"Quality of glycemic control: Assessment using relationships between metrics for safety and efficacy","volume":"23","author":"Rodbard","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/s2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: An international consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70460","article-title":"International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring","volume":"28","author":"Pemberton","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4463-4","article-title":"Improving the clinical value and utility of CGM systems: Issues and recommendations","volume":"60","author":"Petrie","year":"2017","journal-title":"Diabetologia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/193229681300700234","article-title":"Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making: The ambulatory glucose profile","volume":"7","author":"Bergenstal","year":"2013","journal-title":"J Diabetes Sci Technol"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1941126\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:29:01Z","timestamp":1789532941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1941126\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":25,"alternative-id":["10.3389\/fcdhc.2026.1941126"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2026.1941126","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1941126"}}